Janka Lincoln, M.D.

Professional Background

Jana Lincoln, M.D. is a board-certified psychiatrist. She specializes in the assessment and treatment of patients with severe mental illness who are hospitalized in the civilian hospital as well as in the forensic unit of the state hospital. Additionally, she performs electroconvulsive treatment (ECT). Dr. Lincoln is Director of Clinical Services and Program Director for the Residency program. Dr. Lincoln graduated from Comenius University - Jessenius Faculty of Medicine in the Slovak Republic and completed her residency in psychiatry at the KU School of Medicine in Wichita. She has additional training in ECT from Duke University and training in Principles of Medical Education from Harvard University.

• MD, General Medicine, Comenius University, Jessenius Faculty of Medicine, Martin, Slovakia
• Residency, Psychiatry, University of Kansas School of Medicine-Wichita, Wichita, KS
• Other, Clinical Education, Harvard School of Medicine, Cambridge, MA, Boston, Massachusetts
• Other, Electroconvulsive Treatment (ECT), Duke University Medical Center, Durham, NC, Durham, North Carolina

• General Psychiatry, American Board of Psychiatry and Neurology
• Kansas Board of Healing Arts Medical License, Kansas Board of Healing Arts
• National Plan and Provider Enumeration System NPPES, National Plan and Provider Enumeration System

• American Psychiatric Association, Area 4 Representative, Member, 2020 - 2022
• Kansas Psychiatric Society (KPS), American Psychiatric Association Area 4 Representative, 2020 - 2022
• American Psychiatric Association, Distinguished Fellow, 2018 - Present
• International Society for ECT and Neurostimulation, Member, 2017 - Present
• Kansas Psychiatric Society (KPS), Election Committee Chair and Member, 2016 - 2024
• Ascension - Via Christi Wichita, Ascension Via Christi, Wichita, Pharmacy and Therapeutics Committee, Member , 2015 - 2022
• Ascension - Via Christi Wichita, Ascension Via Christi, Wichita, Project Mayflower, Director for Implementation in Behavioral Health Service Line, 2013 - 2014

---

• Kalu, Walter, Lincoln, Jana, Troutman, Megan. 2018. Case Presentation: Lithium-Haloperidol Induced Neurotoxicity and Catatonia in Patient With Bipolar Mania With Psychosis: Diagnosis and Treatment. http://www.psychcongress.com/posters/case-presentation-lithium-haloperidol-induced-neurotoxicity-and-catatonia-patient-bipolar
• Flynn, A, Lincoln, J, Burke, M. 2016. Homicidality and Psychosis Caused by an Over-the-Counter Performance-Enhancing Supplement Containing Dendrobium Extract and L-Dopa.. P & T : a peer-reviewed journal for formulary management, 41 (6), 381-4
• Lincoln, Jana, Wehler, Cheryl. 2013. Out of Pipeline - Vortioxetine for Major Depressive Disorder. Current Psychiatry, 13 (2), 67-70
• Lincoln, Jana, Tripathi, Aveekshit. 2011. Out of Pipeline – Lurasidone for Schizophrenia. Current Psychiatry, 10 (1), 67-70
• Lincoln, J, Stewart, M., E, Preskorn, S., H. 2010. How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.. Journal of psychiatric practice, 16 (2), 103-14
• Lincoln, Jana, Preskorn, Sheldon., H. 2009. Out of Pipeline – Asenapine. Current Psychiatry, 8 (12), 75-85
• Burke, M., J, Lincoln, J. 2006. Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist.. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 (2), 129-30
• Burke, Michael., J, Lincoln, Jana, Rakel, R., E, Bope, E. 2006. Mood Disorders, 2006